BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17366343)

  • 1. Could pharmacogenetics play a role as predictor in treatment of depressive disorders?
    Lee MS
    World J Biol Psychiatry; 2007; 8(1):2-3. PubMed ID: 17366343
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenetics in modern psychiatry.
    Mihaljević-Peles A; Bozina N; Sagud M
    Psychiatr Danub; 2007 Sep; 19(3):231-3. PubMed ID: 17914325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharamacogenetics and antidepressant treatment in integrative psychiatry perspective.
    Mihaljević-Peles A; Sagud M; Bozina N; Zivković M
    Psychiatr Danub; 2008 Sep; 20(3):399-401. PubMed ID: 18827770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights and barriers to clinical use of serotonin transporter pharmacogenetics in antidepressant therapy.
    Stevenson JM
    Pharmacogenomics; 2018 Feb; 19(3):167-170. PubMed ID: 29325499
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacotherapeutic approaches to treatment-resistant depression.
    St John D
    JAAPA; 2003 Mar; 16(3):32-4, 37-8, 40 passim. PubMed ID: 14968524
    [No Abstract]   [Full Text] [Related]  

  • 6. Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse.
    Weizman A; Weizman R
    Pharmacogenomics; 2000 Aug; 1(3):335-41. PubMed ID: 11256582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics and antidepressant drugs.
    Binder EB; Holsboer F
    Ann Med; 2006; 38(2):82-94. PubMed ID: 16581694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of genetic variations on the effect of selective serotonin reuptake inhibitors].
    Bukh JO; Bock C; Mors NP; Kessing LV
    Ugeskr Laeger; 2007 Apr; 169(16):1439-41. PubMed ID: 17484840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticipated outcomes from introduction of 5-HTTLPR genotyping for depressed patients: an expert Delphi analysis.
    Oestergaard S; Møldrup C
    Public Health Genomics; 2010; 13(7-8):406-14. PubMed ID: 20606382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TORDIA: unique opportunity to explore half-life theory.
    Smith E
    Am J Psychiatry; 2009 Aug; 166(8):936; author reply 936-7. PubMed ID: 19651756
    [No Abstract]   [Full Text] [Related]  

  • 11. [Medical interactions with antidepressives. Benefits of the specific serotonin reuptake inhibitor citalopram].
    Eckert A; Reiff J; Müller WE
    Med Monatsschr Pharm; 1998 May; 21(5):138-50. PubMed ID: 9617102
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.
    Henry NL; Stearns V; Flockhart DA; Hayes DF; Riba M
    Am J Psychiatry; 2008 Oct; 165(10):1251-5. PubMed ID: 18829880
    [No Abstract]   [Full Text] [Related]  

  • 13. Vilazodone (Viibryd)--a new antidepressant.
    Med Lett Drugs Ther; 2011 Jul; 53(1368):53-4. PubMed ID: 21738107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin transporter gene polymorphism and antidepressant response.
    Kim DK; Lim SW; Lee S; Sohn SE; Kim S; Hahn CG; Carroll BJ
    Neuroreport; 2000 Jan; 11(1):215-9. PubMed ID: 10683861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic and clinical predictors of treatment efficacy in depressive disorders].
    Ivanets NN; Kinkulkina MA; Tikhonova YG; Izumina TA; Avdeeva TI; Morozov DI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):55-64. PubMed ID: 29171490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.
    Kato M; Ikenaga Y; Wakeno M; Okugawa G; Nobuhara K; Fukuda T; Fukuda K; Azuma J; Kinoshita T
    Int Clin Psychopharmacol; 2005 May; 20(3):151-6. PubMed ID: 15812265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Do antidepressive agents work against depression?].
    Næss MS
    Tidsskr Nor Laegeforen; 2017 May; 137(9):606. PubMed ID: 28468471
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic screening for SSRI drug response among those with major depression: great promise and unseen perils.
    Rasmussen-Torvik LJ; McAlpine DD
    Depress Anxiety; 2007; 24(5):350-7. PubMed ID: 17096399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common selective serotonin reuptake inhibitor side effects in older adults associated with genetic polymorphisms in the serotonin transporter and receptors: data from a randomized controlled trial.
    Garfield LD; Dixon D; Nowotny P; Lotrich FE; Pollock BG; Kristjansson SD; Doré PM; Lenze EJ
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):971-9. PubMed ID: 24021217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological treatment of depression in the elderly].
    Bonin-Guillaume S; Blin O
    Psychol Neuropsychiatr Vieil; 2004 Sep; 2 Suppl 1():S61-8. PubMed ID: 15899646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.